PRIME MEMBER EXCLUSIVE | 3 Months Free Trial
Auto-renews at INR 199/mo after 3 months. Cancel anytime. Offer ends 15 July, 2026.
Episode 4 - SUGAR DIP TRIAL 2025
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.
Add to cart failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Episode 4 - SUGAR DIP TRIAL 2025
-
Narrated by:
-
Written by:
The SUGAR-DIP Trial examines whether a sequential oral medication strategy (Metformin + Glyburide) is non-inferior to insulin for preventing large-for-gestational-age (LGA) infants in gestational diabetes. This episode explores:
- The efficacy of oral agents vs. insulin in glycemic control
- Differences in neonatal outcomes, maternal hypoglycemia, and birth complications
- Why insulin remains the gold standard in gestational diabetes
- Future prospects for oral therapy in pregnancy
adbl_web_anon_alc_button_suppression_t1
No reviews yet